%A Ju,Chun-Rong %A Lian,Qiao-Yan %A Guan,Wei-Jie %A Chen,Ao %A Zhang,Jian-Heng %A Xu,Xin %A Chen,Rong-Chang %A Li,Shi-Yue %A He,Jian-Xing %D 2022 %J Transplant International %C %F %G English %K infection,metagenomic next-generation sequencing,lung transplant recipients,pathogen,conventional detection methods %Q %R 10.3389/ti.2022.10265 %W %L %M %P %7 %8 2022-February-10 %9 Original Research %# %! mNGS in LTRs %* %< %T Metagenomic Next-Generation Sequencing for Diagnosing Infections in Lung Transplant Recipients: A Retrospective Study %U https://www.frontierspartnerships.org/articles/10.3389/ti.2022.10265 %V 35 %0 JOURNAL ARTICLE %@ 1432-2277 %X Background: Accurate identification of pathogens is essential for the diagnosis and control of infections. We aimed to compare the diagnostic performance of metagenomic next-generation sequencing (mNGS) and conventional detection methods (CDM) in lung transplant recipients (LTRs).Methods: We retrospectively analyzed 107 LTRs with suspected infection of pulmonary, blood, central nervous system or chest wall between March 2018 and November 2020. Bronchoalveolar lavage fluid and other body fluids were subject to pathogen detection by both mNGS and CDM.Results: Of the 163 specimens, 84 (51.5%) tested positive for both mNGS and culture, 19 (11.7%) of which were completely consistent, 44 (27.0%) were partially congruent, and 21 (12.9%) were discordant (kappa = .215; p = .001). Compared with CDM, mNGS detected a higher diversity of pathogens. Moreover, the turn-around time was significantly shorter for mNGS compared with culture (2.7 ± .4 vs. 5.5 ± 1.6 days, p < .001). As an auxiliary method, treatment strategies were adjusted according to mNGS findings in 31 cases (29.0%), including eight patients with non-infectious diseases, who were finally cured.Conclusion: mNGS can identify pathogens with a shorter turn-around time and therefore provide a more accurate and timely diagnostic information to ascertaining pulmonary infections. mNGS might have a role in differentiating infectious from non-infectious lung diseases in LTRs.